Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

BAC
Bank of America Corporation
stock NYSE

Market Open
Jun 5, 2026 3:37:07 PM EDT
53.71USD-0.858%(-0.46)24,498,090
53.70Bid   53.71Ask   0.01Spread
Pre-market
Jun 5, 2026 9:29:30 AM EDT
54.27USD+0.185%(+0.10)69,883
After-hours
Jun 4, 2026 4:52:30 PM EDT
54.10USD-0.018%(-0.01)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsTrends
BAC Reddit Mentions
Subreddits
Limit Labels     

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.
Take me to the API
BAC Specific Mentions
As of Jun 5, 2026 3:14:22 PM EDT (23 minutes ago)
Includes all comments and posts. Mentions per user per ticker capped at one per hour.
8 days ago • u/King_Chron • r/weedstocks • why_the_build_act_catalyzes_cannabix_blozf • C
The fundamental conflict between marketing claims and biological reality forces a sharp divergence in how criminal courts and private corporations view cannabis breath technology. While companies like Cannabix Technologies pitch their devices as a definitive solution for recent use detection, federal and independent research has repeatedly verified that chronic users can harbor baseline THC concentrations in their breath that mimic active, recent intoxication. This lack of data separation creates entirely different sets of legal and functional realities for judges and corporate executives.
In criminal law, a positive breath test from a device measuring a single snapshot of Delta9THC is currently scientifically indefensible due to a lack of baseline distinction and clear impairment metrics. Becausen Delta9THC is highly lipophilic (fat-soluble), daily or medical cannabis users continuously slowly bleed stored THC from fatty tissues back into their circulatory system and lung lining. A pilot study published in the [*Journal of Breath Research*](https://pmc.ncbi.nlm.nih.gov/articles/PMC10201171/) demonstrated that daily cannabis users frequently have active THC present in their breath aerosols despite verified abstinence of 12 to 24 hours. Furthermore, a joint study by the [National Institute of Standards and Technology (NIST)](https://www.nist.gov/news-events/news/2023/05/researchers-analyze-thc-breath-cannabis-smokers) and the University of Colorado Boulder confirmed that the quantitative amount of THC found in a regular user's breath *prior* to consuming cannabis on any given day can be virtually identical to the amount found in their breath *an hour after* active consumption. This led federal researchers to conclude in an official report summarized by [*Marijuana Moment*](https://www.marijuanamoment.net/federal-researchers-claim-first-ever-detection-of-cannabinoids-in-human-breath-after-use-of-marijuana-edibles/) that data does "not support the idea that detecting THC in breath as a single measurement could reliably indicate recent cannabis use." Additionally, unlike alcohol's linear relationship with Blood Alcohol Concentration (BAC), there is zero scientific consensus linking a specific picogram level of breath THC to motor or cognitive impairment, with a comprehensive review in [*Scientific Reports (Nature)*](https://www.nature.com/articles/s41598-021-02137-x) highlighting that no meaningful correlation has been established between impairment and Delta9THC levels in any tested matrix to date. Consequently, a defense attorney can easily introduce reasonable doubt by demonstrating that a positive breath test from a daily user reflects a sober, resting baseline rather than active, recent intoxication at the wheel.
Conversely, for private employers managing safety-sensitive jobs like construction, manufacturing, and transport, the technical flaws that ruin a courtroom case are treated as an acceptable risk margin. Employers primarily look to filter out the weekend or occasional consumer, knowing that if an occasional user smokes on a Friday night, their breath clears completely by Saturday morning; a positive test on Monday morning thus provides a reasonable deduction of weekday impairment. While companies accept that this technology unfairly catches chronic or medical users who are not actively impaired, corporate risk management views a "false positive" on a sober but frequent user as a safe compliance buffer. Unlike criminal prosecutors who must prove impairment "beyond a reasonable doubt," employers rely on at-will employment and collective bargaining agreements to enforce internal policies. As outlined in [Cannabix Technologies' own regulatory disclosures](https://cannabixtechnologies.com/site/assets/files/6587/2024_md_a_cannabix_-_final.pdf), companies utilize these tests simply to establish compliance with arbitrary "zero-tolerance" or "clear-headed duty" workplace rules, granting administrative justification to terminate or suspend an employee and shielding the business from workplace liability insurance spikes.
sentiment 0.49
8 days ago • u/King_Chron • r/weedstocks • why_the_build_act_catalyzes_cannabix_blozf • C
The fundamental conflict between marketing claims and biological reality forces a sharp divergence in how criminal courts and private corporations view cannabis breath technology. While companies like Cannabix Technologies pitch their devices as a definitive solution for recent use detection, federal and independent research has repeatedly verified that chronic users can harbor baseline THC concentrations in their breath that mimic active, recent intoxication. This lack of data separation creates entirely different sets of legal and functional realities for judges and corporate executives.
In criminal law, a positive breath test from a device measuring a single snapshot of Delta9THC is currently scientifically indefensible due to a lack of baseline distinction and clear impairment metrics. Becausen Delta9THC is highly lipophilic (fat-soluble), daily or medical cannabis users continuously slowly bleed stored THC from fatty tissues back into their circulatory system and lung lining. A pilot study published in the [*Journal of Breath Research*](https://pmc.ncbi.nlm.nih.gov/articles/PMC10201171/) demonstrated that daily cannabis users frequently have active THC present in their breath aerosols despite verified abstinence of 12 to 24 hours. Furthermore, a joint study by the [National Institute of Standards and Technology (NIST)](https://www.nist.gov/news-events/news/2023/05/researchers-analyze-thc-breath-cannabis-smokers) and the University of Colorado Boulder confirmed that the quantitative amount of THC found in a regular user's breath *prior* to consuming cannabis on any given day can be virtually identical to the amount found in their breath *an hour after* active consumption. This led federal researchers to conclude in an official report summarized by [*Marijuana Moment*](https://www.marijuanamoment.net/federal-researchers-claim-first-ever-detection-of-cannabinoids-in-human-breath-after-use-of-marijuana-edibles/) that data does "not support the idea that detecting THC in breath as a single measurement could reliably indicate recent cannabis use." Additionally, unlike alcohol's linear relationship with Blood Alcohol Concentration (BAC), there is zero scientific consensus linking a specific picogram level of breath THC to motor or cognitive impairment, with a comprehensive review in [*Scientific Reports (Nature)*](https://www.nature.com/articles/s41598-021-02137-x) highlighting that no meaningful correlation has been established between impairment and Delta9THC levels in any tested matrix to date. Consequently, a defense attorney can easily introduce reasonable doubt by demonstrating that a positive breath test from a daily user reflects a sober, resting baseline rather than active, recent intoxication at the wheel.
Conversely, for private employers managing safety-sensitive jobs like construction, manufacturing, and transport, the technical flaws that ruin a courtroom case are treated as an acceptable risk margin. Employers primarily look to filter out the weekend or occasional consumer, knowing that if an occasional user smokes on a Friday night, their breath clears completely by Saturday morning; a positive test on Monday morning thus provides a reasonable deduction of weekday impairment. While companies accept that this technology unfairly catches chronic or medical users who are not actively impaired, corporate risk management views a "false positive" on a sober but frequent user as a safe compliance buffer. Unlike criminal prosecutors who must prove impairment "beyond a reasonable doubt," employers rely on at-will employment and collective bargaining agreements to enforce internal policies. As outlined in [Cannabix Technologies' own regulatory disclosures](https://cannabixtechnologies.com/site/assets/files/6587/2024_md_a_cannabix_-_final.pdf), companies utilize these tests simply to establish compliance with arbitrary "zero-tolerance" or "clear-headed duty" workplace rules, granting administrative justification to terminate or suspend an employee and shielding the business from workplace liability insurance spikes.
sentiment 0.49


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC